Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 31 Mar 2022 |
10 | Order | 08 Apr 2024 |
11 | Note Sheet | 08 Apr 2024 |
12 | Forwarding Letter for TM-6 | 09 Apr 2024 |
13 | Evidence Affidavit Under Rule 46 (TOP) | 09 Aug 2024 |
14 | Annexure -1 under rule 46 | 09 Aug 2024 |
2 | Journal Copy | 16 Aug 2022 |
3 | TM-O(NOTICE OF OPPOSITION) | 13 Sep 2022 |
4 | TM-O(NOTICE OF OPPOSITION) | 19 Oct 2022 |
5 | Evidence Affidavit Under Rule 46 (TOP) | 17 Jun 2023 |
6 | Annexure -1 under rule 46 | 17 Jun 2023 |
7 | Hearing Notice | 19 Dec 2023 |
8 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 22 Jan 2024 |
9 | Hearing Notice | 20 Feb 2024 |
1 | Opposition Notice | 14430192 | 5785671 | 05 Dec 2022 |
2 | Opposition Notice | 14474862 | 5796583 | 13 Dec 2022 |
3 | Opposition Counter Statement | 14741183 | 5850257 | 03 Feb 2023 |
4 | Opposition Counter Statement | 14812642 | 5865458 | 17 Feb 2023 |
5 | Opposition Counter Statement | 17913958 | 6682399 | 09 Apr 2024 |
The application for Liprosuva was made on 31 March 2022.
The trademark applicant for Liprosuva is CAPLIN POINT LABORATORIES.
Liprosuva is applied in class(es) 5.
Application for Liprosuva is on Opposed stage.
Application Id allotted to Liprosuva is 5392621.
Trademark agent or attorney for the application is Mission Legal Advocates.
Liprosuva filed with the Intellectual property office as a WORD.